Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-11-06 4:31 pm Purchase | 13G | HARPOON THERAPEUTICS INC N HARP | RA CAPITAL MANAGEMENT L.P. | 1,701,570 9.99% | 1,701,570 (New Position) | View |
| 2023-10-30 4:45 pm Purchase | 13G | MACROGENICS INC MGNX | RA CAPITAL MANAGEMENT L.P. | 3,764,871 6.1% | 3,764,871 (New Position) | View |
| 2023-10-05 5:09 pm Purchase | 13G | SOLENO THERAPEUTICS INC PA SLNO | RA CAPITAL MANAGEMENT L.P. | 1,233,300 4.6% | 1,233,300 (New Position) | View |
| 2023-09-29 4:54 pm Purchase | 13G | CHIMERIX INC CMRX | RA CAPITAL MANAGEMENT L.P. | 6,501,624 7.3% | 6,501,624 (New Position) | View |
| 2023-09-25 4:30 pm Purchase | 13D | ARS PHARMACEUTICALS, INC SPRY | RA CAPITAL MANAGEMENT L.P. | 9,459,678 9.9% | 2,700,000 (+39.94%) | View |
| 2023-09-22 4:30 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | RA CAPITAL MANAGEMENT L.P. | 6,940,000 6.2% | 6,940,000 (New Position) | View |
| 2023-09-19 5:25 pm Sale | 13D | CYTEK BIOSCIENCES INC CTKB | RA CAPITAL MANAGEMENT L.P. | 6,809,404 4.99% | -6,329,923 (-48.18%) | View |
| 2023-08-31 5:25 pm Purchase | 13D | ARS PHARMACEUTICALS, INC SPRY | RA CAPITAL MANAGEMENT L.P. | 6,759,678 7.07% | 5,017,492 (+288.00%) | View |
| 2023-08-25 5:01 pm Purchase | 13G | TAYSHA GENE THERAPIES INC TSHA | RA CAPITAL MANAGEMENT L.P. | 18,690,868 9.99% | 18,690,868 (New Position) | View |
| 2023-08-21 4:30 pm Purchase | 13G | GRACELL BIOTECHNOLOGIES INC SP GRCL | RA CAPITAL MANAGEMENT L.P. | 48,600,300 9.99% | 48,600,300 (New Position) | View |
| 2023-08-17 4:30 pm Purchase | 13G | NEKTAR THERAPEUTICS NKTR | RA CAPITAL MANAGEMENT L.P. | 18,700,000 9.8% | 18,700,000 (New Position) | View |
| 2023-08-14 5:01 pm Sale | 13G | BELLUS HEALTH INC BLU | RA CAPITAL MANAGEMENT L.P. | 0 0% | -12,452,574 (Position Closed) | View |
| 2023-08-14 5:00 pm Sale | 13G | KINNATE BIOPHARMA INC KNTE | RA CAPITAL MANAGEMENT L.P. | 0 0% | -4,264,144 (Position Closed) | View |
| 2023-08-11 5:05 pm Purchase | 13D | VOR BIOPHARMA INC.COM VOR | RA CAPITAL MANAGEMENT L.P. | 22,780,343 33.7% | 20,198 (+0.09%) | View |
| 2023-08-11 5:01 pm Sale | 13D | 89BIO INC ETNB | RA CAPITAL MANAGEMENT L.P. | 12,874,814 16.7% | -2,084 (-0.02%) | View |
| 2023-08-09 5:00 pm Sale | 13D | DICE THERAPEUTICS INC DICE | RA CAPITAL MANAGEMENT L.P. | 0 0% | -7,877,862 (Position Closed) | View |
| 2023-08-01 4:30 pm Purchase | 13G | NEWAMSTERDAM PHARMA CO NV SHS NAMS | RA CAPITAL MANAGEMENT L.P. | 9,333,333 11.3% | 5,000,000 (+115.38%) | View |
| 2023-07-25 4:31 pm Purchase | 13D | ACUMEN PHARMACEUTICALS INC ABOS | RA CAPITAL MANAGEMENT L.P. | 14,981,618 25.9% | 5,207,067 (+53.27%) | View |
| 2023-07-06 4:32 pm Purchase | 13G | TALARIS THERAPEUTICS INC TALS | RA CAPITAL MANAGEMENT L.P. | 2,333,175 5.5% | 2,333,175 (New Position) | View |
| 2023-07-06 4:30 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | RA CAPITAL MANAGEMENT L.P. | 3,470,689 9.99% | 3,470,689 (New Position) | View |